Education
About Us
Working with TipRanks
Follow Us
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 829.45M | $ 3.55M | $ 240.74M | $ 243.23M | $ 138.29M |
| Gross Profit | $ 0.00 | $ 3.55M | $ 240.74M | $ 243.23M | $ 138.29M |
| Operating Income | $ 98.35M | $ -601.08M | $ -205.00M | $ -178.51M | $ -149.04M |
| EBITDA | $ 98.35M | $ -561.51M | $ -175.67M | $ -162.29M | $ -132.58M |
| Net Income | $ -1.63M | $ -599.49M | $ -205.28M | $ -176.06M | $ -140.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 919.37M | $ 680.96M | $ 403.63M | $ 376.40M | $ 367.79M |
| Total Assets | $ 1.45B | $ 1.14B | $ 765.55M | $ 691.94M | $ 710.15M |
| Total Debt | $ 733.68M | $ 851.91M | $ 383.50M | $ 81.58M | $ 25.55M |
| Net Debt | $ 507.13M | $ 749.23M | $ 272.61M | $ -26.43M | $ -158.89M |
| Total Liabilities | $ 947.02M | $ 948.74M | $ 478.39M | $ 273.60M | $ 301.33M |
| Stockholders' Equity | $ 466.05M | $ 185.44M | $ 271.34M | $ 398.52M | $ 408.82M |
| Cash Flow | |||||
| Free Cash Flow | $ 156.89M | $ -604.32M | $ -330.63M | $ -188.91M | $ 147.66M |
| Operating Cash Flow | $ 179.55M | $ -462.85M | $ -153.89M | $ -136.13M | $ 171.22M |
| Investing Cash Flow | $ -129.29M | $ -420.07M | $ -96.16M | $ -5.42M | $ -141.68M |
| Financing Cash Flow | $ 74.01M | $ 870.52M | $ 253.05M | $ 65.19M | $ 11.30M |